Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_56843638 Show fit | 1.27 |
ENST00000421834.6
ENST00000370788.6 |
dystonin |
|
chr15_-_58065734 Show fit | 1.21 |
ENST00000347587.7
|
aldehyde dehydrogenase 1 family member A2 |
|
chr1_-_42456006 Show fit | 1.18 |
ENST00000372565.8
|
zinc finger MYND-type containing 12 |
|
chr15_-_58065703 Show fit | 1.13 |
ENST00000249750.9
|
aldehyde dehydrogenase 1 family member A2 |
|
chr15_-_58065870 Show fit | 1.08 |
ENST00000537372.5
|
aldehyde dehydrogenase 1 family member A2 |
|
chr22_-_24593038 Show fit | 1.05 |
ENST00000318753.13
|
leucine rich repeat containing 75B |
|
chr9_-_109498251 Show fit | 1.04 |
ENST00000374541.4
ENST00000262539.7 |
protein tyrosine phosphatase non-receptor type 3 |
|
chrX_-_126552801 Show fit | 0.86 |
ENST00000371126.3
|
DDB1 and CUL4 associated factor 12 like 1 |
|
chr6_-_56843153 Show fit | 0.84 |
ENST00000361203.7
ENST00000523817.1 |
dystonin |
|
chr10_+_110644306 Show fit | 0.84 |
ENST00000369519.4
|
RNA binding motif protein 20 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.4 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 1.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 1.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.8 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.4 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.3 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.2 | GO:0002357 | defense response to tumor cell(GO:0002357) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | GO:0031673 | H zone(GO:0031673) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 2.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 1.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |